Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
Have you forgotten your password?
Home
.National Taiwan University / 國立臺灣大學
Project / 研究計畫
(100CAP020-2) in vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (I)
(100CAP020-2) in vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (I)
Details
Primary Data
Project title
超越Sorafenib---探詢肝細胞癌的新穎治療標的及生物指標---(子計畫二)肝細胞癌對Sorafenib具抗藥性的活體實驗模式:著重預測生物標記及抗藥性反轉策略之研發(I)
Internal ID
NSC100-2325-B002-043
Principal Investigator
CHIH-HUNG HSU
Start Date
May 1, 2011
End Date
April 12, 2012
Partner Organizations
National Science and Technology Council
Project Web Site
http://grbsearch.stpi.narl.org.tw/search/planDetail2?id=2317248
Description
Keywords
肝細胞癌
sorafenib
抗藥性
活體實驗模式
Hepatocellular carcinoma
sorafenib
drug resistance
in vivo model